Announcement on Convening 2017 Annual Performance and Cash Dividend Explanation Meeting
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2018-009
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
on Convening 2017 Annual Performance and Cash Dividend Explanation Meeting
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
Important Content Note:
l Meeting Time: April 26, 2018 15:00-16:00
l Meeting Place: Investors can log on the following website to participate in this briefing online: http://sns.sseinfo.com .
l Meeting Method: Network Platform
1. Description Meeting Type
Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company") held the 3rd meeting of the 10th Board of Directors on April 20, 2018 to deliberate and pass the "2017 Profit Distribution Proposal". The announcement of the meeting resolution was published on the designated information disclosure media and the website of Shanghai Stock Exchange (www.sse.com.cn ) on April 24, 2018.
In accordance with the "Guidelines for Cash Dividends of Listed Companies on the Shanghai Stock Exchange", "Notice on Promoting the Work of Listed Companies to Hold Investor Briefings" and other relevant regulations, in order to enable investors to have a more comprehensive and in-depth understanding of the company, the company Decided to hold a 2017 annual performance and cash dividend briefing to fully communicate with investors on the company's 2017 performance and profit distribution. The time and place of the
2. explanation meeting
company is scheduled to have online communication with investors through the "Shanghai e interview" column of the "Shanghai e interaction" network platform (http://sns.sseinfo.com) of Shanghai stock exchange on April 26, 2018 from 15:00 p.m. to 16:00 p.m.
3. Participants
Company Chairman Jiang Xiaomeng, General Manager Yu Jianhong, Chief Financial Officer Lan Xiaolong, and Board Secretary Zhu Jianwei. (If there are special circumstances, the participants may be adjusted)
4. the way for investors to participate
(I) The company welcomes investors to contact the company by telephone, fax, email, etc. before the briefing, and ask For the information and concerns, the company will answer the questions that investors are generally concerned about at the briefing.
(II) investors can register through the internet and log on the internet platform (http://sns.sseinfo.com) from 15:00 p.m. to 16:00 p.m. on April 26, 2018 to attend this briefing online.
5. contact person and consultation method
person in charge and contact information of the investor briefing meeting of listed companies.
Contact: Zhu Jianwei, Zhou Hengbin
Tel: 0579-82320582 , 82324699
Fax: 0579-89324699
Email: jf@jianfeng.com.cn
This is to announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 20, 2002
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31